FONAR CORP (FONR) Latest Filing Signal

Latest Filing: 10-Q  |  Filed Feb 13, 2026

Cross-checked across multiple AI analysts and grounded in the latest SEC filing.

powered by: earningsVibe.ai

Question:
What is the latest filing signal for FONAR CORP?
Answer:
Based on earningsVibe SuperAnalyst™ synthesis of the latest 10-Q, FONAR CORP's filing signal continuing negative.
earningsVibe SuperAnalyst™ Verdict: CONTINUING NEGATIVE

Signal Performance — Stock Price Since Filing

30-Day Change
-0.70%
from filing date
60-Day Change
Pending
from filing date

Underlying analyst views from Perplexity, Gemini, Claude, and ChatGPT

PERPLEXITY
Continuing Negative
GEMINI
Continuing Negative
CLAUDE
Turned Negative
CHATGPT
Continuing Negative

Unlock the Full Filing Analysis

See full earningsSig™ and risksSig™ analysis across 5,000+ companies

Get Started Free →

No credit card required

Question:
What does FONAR CORP actually do?
Answer:
FONAR Corporation designs, manufactures, sells, and services magnetic resonance imaging (MRI) scanners, pioneering the "open" MRI technology and introducing the first commercial MRI scanner in 1980. The company operates through two segments: medical equipment, directly through FONAR, and physician management and diagnostic services via its subsidiary, Health Management Corporation of America (HMCA). HMCA provides comprehensive non-medical management services to diagnostic imaging facilities, managing 44 MRI scanners across New York and Florida, and also owns six diagnostic imaging facilities in Florida. FONAR's primary product is the Upright(R) MRI scanner, which allows for scanning in various weight-bearing postures, a unique offering in the market. The company generates revenue from both the sale of its specialized MRI equipment and from service and upgrade programs for its installed base.
Question:
What are FONAR CORP's revenue drivers?
Answer:
Revenue is driven by the sale of MRI scanners and upgrades, as well as service and maintenance contracts for its installed base. The physician and diagnostic services segment generates revenue through management fees from imaging facilities and direct patient fees from its owned facilities.

Cut through noisy SEC filings to find the signal faster

Source-grounded filing intelligence with one-click links back to the filing, so you can move faster and verify everything at the source.

Get Started Free →

No credit card required